Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-23

Clinical Trial Update: Treatment Tapering in JIA With Inactive Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on treatment tapering for Juvenile Idiopathic Arthritis patients in inactive disease; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Juvenile Idiopathic Arthritis | Phase 3 | Status: COMPLETED